AwardTape · Defense awards · Research and development · Health R&D · HT942523C0095
HT942523C0095: $2.0M definitive contract to Versiti Blood Health, Inc
Versiti Blood Health, Inc holds a definitive contract from Defense Health Agency with $2.0M obligated since Oct 2023 and $6.5M obligated over its life, against a ceiling of $6.5M. Latest action Mar 10, 2026.
Research and development contract - proposal jw220021 - contract proposal title - evaluating the safety and ease of use of counterflow hemostatic gauze for extreme cold environments
| PIID | HT942523C0095 |
|---|---|
| Type | definitive contract |
| Company | Versiti Blood Health, Inc |
| Agency | Defense Health Agency |
| Contracting office | ARMY MED RES ACQ ACTIVITY |
| Category | Research and development · Health R&D |
| PSC | AN12 HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| NAICS | 541714 RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| Obligated since Oct 2023 | $2.0M |
| Total obligated (lifetime) | $6.5M |
| Ceiling (base and all options) | $6.5M |
| Base date | Sep 25, 2023 |
| Latest action | Mar 10, 2026 |
| End date | Dec 24, 2026 |
| Actions since Oct 2023 | 4 |
| Pricing | Cost no fee |
| Competition | Full and open competition |
| Place of performance | WI |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial